Zoic Capital
Zoic Capital is the only US-based venture firm focused on early-stage healthcare innovations at the intersection of life sciences and medical technology. Promising Scientific Advancements: We look for breakthroughs with the potential for broad IP and commercial-ready maturity. We invest in roadmaps that leverage a core innovation across many applications and industries. Focus on Life Sciences: We see the most exciting advancements coming from life sciences labs, becoming tools that maintain and treat our health. We look at both technologies that enable development and care delivery devices. We Follow the Numbers: We follow our gut, but we also reinforce each of our decisions with numbers. We believe that merging qualitative and quantitative analysis is the best way to make successful investment decisions. Mentored Capital: We have the skills, experience and network to help, working closely with select teams to transform research into high impact, market-ready products. Milestone-Based Investing: We craft unique deal structures for each portfolio company based on mutually defined milestones. We find this approach creates ongoing momuntum and sets us all up for success.
ProbiusDx is an electronic sensing company that provides a diagnostic technology for detecting and monitoring blood concentrations.
HDT Bio is a developer of RNA vaccines and therapeutics based on LION formulation technology. The company's technology platforms and products cover a wide range of immunotherapy modalities and mechanisms of action, including innate immunity activation, adaptive immune response amplification, and tumor-tight junction disruption. Its mission is to maintain the rapid and significant progress made in the fight against the world's deadliest infectious diseases by developing cutting-edge immunotherapy technologies in a cost-effective manner across leading markets as well as low or middle-income countries.
BioROSA Technologies creates a biologically-based diagnostic standard of care for Autism Spectrum Disorders. The company was founded in 2018 and is based in Belmont, Massachusetts.
ODS Medical Inc. is a medical device company that seeks to commercialize their exclusive Raman spectroscopy system for real-time detection of tissue abnormalities through the development, manufacture and sales of products for a range of clinical settings. ODS Medical Inc. is dedicated to bringing to the hands of physicians the next generation of diagnostic tools. Building on our revolutionary proprietary platform technology, we integrate cutting edge optical probes with the most sophisticated software, based on machine learning algorithms, to empower doctors to make critical decisions- in real-time - with unprecedented sensitivity, specificity and accuracy.
Juno Diagnostics is a health technology company democratizing access to high-value genetic information. The company is developing simple, cost-effective devices that enable point-of-need genetic testing. It was founded in 2017 and is based in San Diego, California.
Optina Diagnostics is a diagnostics company that uses innovative retinal imaging and artificial intelligence to provide non-invasive diagnostic test results for under-diagnosed diseases. Optina Diagnostics identifies patient retinal features that assist physicians in assessing patients' health status and disease risk in order to provide timely and appropriate care. Optina Diagnostics reimagines brain health assessment and provides critical information early in disease progression.
InnoVein is a venture-backed medical device company focusing on cardiac and arterial approaches. The company develops and offers an implantable valve that can regularize blood flow in the veins of the elderly suffering from venous insufficiency disease. InnoVein was founded in 2015 and is headquartered in San Carlos, California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.